home / stock / enz / enz news


ENZ News and Press, Enzo Biochem Inc. From 03/17/23

Stock Information

Company Name: Enzo Biochem Inc.
Stock Symbol: ENZ
Market: NYSE
Website: enzo.com

Menu

ENZ ENZ Quote ENZ Short ENZ News ENZ Articles ENZ Message Board
Get ENZ Alerts

News, Short Squeeze, Breakout and More Instantly...

ENZ - Crypto stocks dominate premarket gainers

2023-03-17 08:22:48 ET Enzo Biochem ( NYSE: ENZ ) +73% . PaxMedica ( PXMD ) +27% . FedEx ( FDX ) +11% . BigBear.ai Holdings ( BBAI ) +11% . Riot Blockchain ( RIOT ) +11% . Corbus Pharmaceuticals Holdings ( CRBP ) +10% ...

ENZ - Enzo Biochem stock surges 77% after divesting Clinical Labs unit to Labcorp

2023-03-16 17:07:30 ET Enzo Biochem ( NYSE: ENZ ) on Thursday said it has sold its Clinical Laboratory division to Labcorp ( NYSE: LH ). Financial details of the transaction were not disclosed. “Completion of the sale will position Enzo to assess and exe...

ENZ - Enzo Biochem Agrees to Sell Clinical Laboratory to Labcorp

Significant value unlocked for Enzo shareholders with continued focus on remaining businesses. FARMINGDALE, NY, March 16, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) announced today that it has entered into an agreement for Labcorp (NYSE: LH) to acquire the assets of Enzo’...

ENZ - Enzo Biochem, Inc. (ENZ) Q1 2023 Earnings Call Transcript

Enzo Biochem, Inc. (ENZ) Q1 2023 Earnings Conference Call December 13, 2022 08:30 A.M. ET Company Participants Unidentified Company Representative - IR Hamid Erfanian - CEO Patricia Eckert - Interim CFO Conference Call Participants Presentation Op...

ENZ - Enzo Biochem Non-GAAP EPS of -$0.18, revenue of $18.28M

Enzo Biochem press release ( NYSE: ENZ ): Q1 Non-GAAP EPS of -$0.18. Revenue of $18.28M (-31.1% Y/Y). For further details see: Enzo Biochem Non-GAAP EPS of -$0.18, revenue of $18.28M

ENZ - Enzo Biochem Reports First Quarter Fiscal Year 2023 Financial Results and Provides Business Update

- Enzo Life Sciences reports revenue of $7.1 million and 9% growth in Q1 FY 2023, excluding FX - Engagement with investment bank to provide advisory services including the evaluation of strategic alternatives for the Company is progressing well. - Continuing to make progress ...

ENZ - Enzo Biochem, Inc. to Report First Quarter Fiscal 2023 Financial Results and Business Update on Monday, December 12th

Conference Call and Webcast Scheduled for December 13 th , 8:30 AM ET New York, NY, Dec. 07, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and diagnostics company, announced today that it will report first quarter fiscal 2023 financial a...

ENZ - Enzo Biochem, Inc. Announces Date of Annual Shareholders' Meeting

NEW YORK, NY, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, today announced that its Annual Shareholders’ Meeting will be held on January 31, 2023.  Sharehold...

ENZ - Farmer Bros. Co. Announces Board Refresh and Cooperation Agreement with Stockholders JCP Investment Management and 22NW

NORTHLAKE, Texas, Oct. 31, 2022 (GLOBE NEWSWIRE) -- Farmer Bros. Co. (NASDAQ: FARM) (the “Company”), today announced it has entered into a cooperation agreement (the “Cooperation Agreement”) with JCP Investment Management, LLC (collectively with its affiliates, &...

ENZ - Enzo Biochem appoints Patricia Eckert as interim CFO

Enzo Biochem ( NYSE: ENZ ) appoints Patricia Eckert as interim CFO, succeeding  David Bench, who is departing the company effective November 14, 2022 to pursue a new opportunity. Prior to her nearly five years in various finance roles with Enzo, Ms. Eck...

Previous 10 Next 10